# Lipid droplets and major metabolic disorders

**Authors:** William J. Dechert, Guanglong He

PMC · DOI: 10.1007/s11033-026-11563-x · Molecular Biology Reports · 2026-02-13

## TL;DR

This paper reviews how lipid droplets regulate lipid storage and energy balance, and their role in chronic inflammation and metabolic diseases.

## Contribution

The paper provides a comprehensive review of lipid droplet biogenesis, metabolism, and their impact on chronic inflammation and disease.

## Key findings

- Lipid droplets interact with other organelles to regulate cellular lipid homeostasis.
- Lipolysis in lipid droplets is controlled by specific proteins and kinases.
- Dysregulation of lipid droplet dynamics contributes to chronic inflammation and metabolic disorders.

## Abstract

Lipid droplets (LDs) are ubiquitous subcellular organelles playing crucial roles in lipid and energy homeostasis. They are constantly generated in the intramembrane space of the endoplasmic reticulum (ER) through unique mechanisms. Upon maturation, they bud off from the ER outer membrane into the cytosol, travel through the cytosolic microtubular network, and make contacts to most of the other subcellular organelles to perform their cellular functions. On the one hand, these organelles can grow or fuse with other smaller ones and serve as storage for extra cellular lipid products. On the other hand, when metabolic needs arise such as in nutrient deprivation or during exercises, the esterified lipids inside the LDs undergo stepwise lipolysis, e.g. basal and stimulated lipolysis, under the regulation of a set of proteins and kinases that are specifically targeted to the monolayer phospholipid membrane of the LDs. The dynamic homeostasis of their biogenesis and lipolysis is also intimately related to other cellular signaling pathways in a paracrine or endocrine manner which actively participate in the regulation of cellular homeostasis and systemic health. This review will summarize the current understanding of the underlying mechanisms mediating the biogenesis and metabolic impact of LDs in normal and disease status with a focus on their roles in propelling and sustaining chronic inflammation.

## Full-text entities

- **Diseases:** chronic inflammation (MESH:D007249), metabolic disorders (MESH:D008659)
- **Chemicals:** lipid (MESH:D008055), phospholipid (MESH:D010743)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12904874/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12904874/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12904874/full.md

---
Source: https://tomesphere.com/paper/PMC12904874